BioSyntech, Inc.
BSYI · OTC
3/31/2009 | 3/31/2008 | 3/31/2007 | 3/31/2006 | |
|---|---|---|---|---|
| Market Cap | $15,103 | $24,473 | $46,831 | $19,119 |
| - Cash | $3,803 | $2,836 | $4,040 | $4,639 |
| + Debt | $12,079 | $3,076 | $3,888 | $2,407 |
| Enterprise Value | $23,378 | $24,713 | $46,678 | $16,887 |
| Revenue | $41 | $274 | $243 | $62 |
| % Growth | -85.1% | 12.5% | 295.9% | – |
| Gross Profit | $25 | $172 | $154 | $40 |
| % Margin | 60.8% | 62.8% | 63.1% | 65.2% |
| EBITDA | -$10,617 | -$8,759 | -$7,890 | -$5,806 |
| % Margin | -26,043.2% | -3,197.6% | -3,240.5% | -9,439.7% |
| Net Income | -$12,939 | -$9,269 | -$8,114 | -$6,855 |
| % Margin | -31,739.1% | -3,383.8% | -3,332.4% | -11,145.5% |
| EPS Diluted | -0.13 | -0.1 | -0.09 | -0.17 |
| % Growth | -30% | -11.1% | 47.1% | – |
| Operating Cash Flow | -$9,573 | -$8,386 | -$7,525 | -$6,174 |
| Capital Expenditures | -$233 | -$120 | -$245 | -$259 |
| Free Cash Flow | -$9,806 | -$8,505 | -$7,770 | -$6,433 |